NM

Nalmandi Mohammed Khalid

Active Director Director DIN 10781886
DIN 10781886 First appointment Sep 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Nalmandi Mohammed Khalid

Data last updated:

Nalmandi Mohammed Khalid is a Director at Curespace Healthcare Private Limited (since 2024). The company operates in Healthcare.

DIN 10781886
Primary Designation Director
Industry Healthcare
First Appointment 20 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curespace Healthcare Private Limited U86100KA2024PTC193107
Director20 Sep 20242024Active

Board colleagues of Nalmandi Mohammed Khalid

Directorship timeline

Open interactive timeline →
Curespace Healthcare Private Limited
Premium access

Shareholding and investment profile for Nalmandi Mohammed Khalid

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nalmandi Mohammed Khalid

Nalmandi Mohammed Khalid currently holds 1 directorship: Curespace Healthcare Private Limited (Director, since 20 Sep 2024).

Nalmandi Mohammed Khalid was first appointed on 20 Sep 2024 as Director at Curespace Healthcare Private Limited.

The current boards of Nalmandi Mohammed Khalid's companies include Arjun Sachidanand (Curespace Healthcare Private Limited), Yunus Saleem Mohammed Hussaina (Curespace Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available